Uttar Pradesh Launches Filariasis Campaign in 21 Districts
Uttar Pradesh launched a mass drug administration (MDA) campaign against filariasis on 10 February 2026. Union Health Minister J.P. Nadda inaugurated it virtually, with Uttar Pradesh Deputy Chief Minister Brajesh Pathak also present.
Campaign Coverage and Schedule
The campaign covered 21 affected districts and 64 blocks in the state. It aimed to provide anti-filarial medicines to approximately 1.40 crore people through door-to-door administration by more than 12,000 teams. The campaign was scheduled to run from 10 to 28 February 2026.
Important Facts for Exams
- Disease classification: Human filarial worms are grouped by the body site they affect: lymphatic, subcutaneous or serous cavities.
- Population-wide treatment: Mass drug administration gives medicines to whole populations irrespective of whether individuals are known to have the targeted disease.
- MDA duration: WHO recommends annual lymphatic-filariasis MDA rounds for at least five years, reducing microfilariae prevalence below levels capable of sustaining transmission.
- Co-endemic drug choice: In areas co-endemic for onchocerciasis, diethylcarbamazine is avoided because it can trigger severe reactions; ivermectin-based combinations are used for lymphatic-filariasis control instead.
Originally written on
February 10, 2026
and last modified on
November 19, 2026.
Tags: anti-filarial medicines, Brajesh Pathak, Filariasis, J.P. Nadda, mass drug administration (MDA), Uttar Pradesh